Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Chobanian, AV
   Control of hypertension - An important national priority.
   NEW ENGLAND JOURNAL OF MEDICINE
   
   A.V. Chobanian, "Control of hypertension - An important national priority.", N ENG J MED, 345(7), 2001, pp. 534-535
2. Chobanian, AV
   Control of hypertension. Reply
   NEW ENGLAND JOURNAL OF MEDICINE
   
   A.V. Chobanian, "Control of hypertension. Reply", N ENG J MED, 345(24), 2001, pp. 1779-1780
3. Chobanian, AV; Hill, M
   National Heart, Lung, and Blood Institute workshop on sodium and blood pressure - A critical review of current scientific evidence
   HYPERTENSION
   
   A.V. Chobanian e M. Hill, "National Heart, Lung, and Blood Institute workshop on sodium and blood pressure - A critical review of current scientific evidence", HYPERTENSIO, 35(4), 2000, pp. 858-863
4. Zhang, H; Du, Y; Cohen, RA; Chobanian, AV; Brecher, P
   Adventitia as a source of inducible nitric oxide synthase in the rat aorta
   AMERICAN JOURNAL OF HYPERTENSION
   
   H. Zhang et al., "Adventitia as a source of inducible nitric oxide synthase in the rat aorta", AM J HYPERT, 12(5), 1999, pp. 467-475
5. Hope, S; Brecher, P; Chobanian, AV
   Comparison of the effects of AT(1) receptor blockade and angiotensin converting enzyme inhibition on atherosclerosis
   AMERICAN JOURNAL OF HYPERTENSION
   
   S. Hope et al., "Comparison of the effects of AT(1) receptor blockade and angiotensin converting enzyme inhibition on atherosclerosis", AM J HYPERT, 12(1), 1999, pp. 28-34
6. DU Y; CHOBANIAN AV; BRECHER P
   ATHEROSCLEROSIS IS REDUCED IN APOLIPOPROTEIN E-DEFICIENT MICE TREATEDWITH PRAZOSIN AND LOSARTAN
   Hypertension
   
   Y. Du et al., "ATHEROSCLEROSIS IS REDUCED IN APOLIPOPROTEIN E-DEFICIENT MICE TREATEDWITH PRAZOSIN AND LOSARTAN", Hypertension, 32(3), 1998, pp. 91-91
7. Makaritsis, KP; Gavras, H; Du, Y; Chobanian, AV; Brecher, P
   alpha(1)-adrenergic plus angiotensin receptor blockade reduces atherosclerosis in apolipoprotein E deficient mice
   HYPERTENSION
   
   K.P. Makaritsis et al., "alpha(1)-adrenergic plus angiotensin receptor blockade reduces atherosclerosis in apolipoprotein E deficient mice", HYPERTENSIO, 32(6), 1998, pp. 1044-1048
8. TAKIZAWA T; GU M; CHOBANIAN AV; BRECHER P
   EFFECT OF NITRIC-OXIDE ON DNA-REPLICATION INDUCED BY ANGIOTENSIN-II IN RAT CARDIAC FIBROBLASTS
   Hypertension
   
   T. Takizawa et al., "EFFECT OF NITRIC-OXIDE ON DNA-REPLICATION INDUCED BY ANGIOTENSIN-II IN RAT CARDIAC FIBROBLASTS", Hypertension, 30(5), 1997, pp. 1035-1040
9. BLACK HR; COHEN JD; KAPLAN NM; FERDINAND KC; CHOBANIAN AV; DUSTAN HP; GIFFORD RW; MOSER M; SHEPS SG; AGODOA L; AUGUST PA; BAKRIS GL; BURT V; BUSSE W; CARTER BL; CHESLEY FD; CLEEMAN J; COHN JN; CREGLER LL; CRESPO C; CUSHMAN WC; CUTLER J; DARROW MD; DEQUATTRO VL; DEVEREUX RB; DWORKIN LD; ELLIOTT WJ; EPSTEIN M; FALKNER B; FERRARIO CM; FLACK JM; FRISHMAN W; FROHLICH ED; GREEN LA; GRIMM RH; HAGBERG JM; HALL WD; HANDLER J; HAVAS S; HILL MN; HORAN MJ; HSUEH WA; HYMAN BN; IZZO JL; JAMERSON K; KILEY JP; KOCHAR MS; KOLASA KM; KRAKOFF LR; LEVY D; LINDHEIMER MD; LUEPKER RV; MALONE MEL; MASSIE B; MATERSON BJ; MERCHANT J; MESSERLI FH; MILLER NH; MOORE MA; MUSTONEALEXANDER L; OPARIL S; PERRY HM; PICKERING TG; PRATT JH; RAM CVS; RANDALL OS; REED JW; ROBERTS RW; ROCCELLA EJ; ROGUS SD; SAUNDERS E; SCHRON E; SCHWARTZ G; SIBAI BM; SNYDER D; SOWERS JR; STAMLER J; TEMPLE R; TEXTOR S; THOM T; VIDT DG; WEBER M; WEINBERGER MH; WEINSHILBOUM R; WHELTON PK; WHISNANT JP; WIEBERS DO; WINSTON MC; WRIGHT JT; LENFANT C; CASSER L; COLMAN PJ; EDWARDS T; FEELEY DM; GAJEWSKI J; LEVINE D; MANGER W; MARSHALL EC; NICKEY WA; ROBERT RW; SECREST BG; SINGER EH; WHISNANT JP; WILSON GJ; YOUNG JM; BACHMAN JW; CAMPESE VM; CARR AA; HAND M; HOLDEN DC; JAMIESON MJ; JULIUS S; MENSAH GA; PRISANT M; SULLIVAN JM; WILSON DJ; MOROSCO G; ANDERSON DE; WAUGH D
   THE 6TH REPORT OF THE ,-EVALUATION,-AND-TREATMENT-OF-HIGH-BLOOD-PRESSURE
   Archives of internal medicine
   
   H.R. Black et al., "THE 6TH REPORT OF THE ,-EVALUATION,-AND-TREATMENT-OF-HIGH-BLOOD-PRESSURE", Archives of internal medicine, 157(21), 1997, pp. 2413-2446
10. TAKIZAWA T; FARIVAR RS; CHOBANIAN AV; BRECHER P
    OPPOSING EFFECTS OF ANGIOTENSIN-II AND NITRIC-OXIDE ON RAT CARDIAC FIBROBLAST PROLIFERATION
    The FASEB journal
    
    T. Takizawa et al., "OPPOSING EFFECTS OF ANGIOTENSIN-II AND NITRIC-OXIDE ON RAT CARDIAC FIBROBLAST PROLIFERATION", The FASEB journal, 10(3), 1996, pp. 1913-1913
11. TAKIZAWA T; CHOBANIAN AV; BRECHER P
    THE EFFECT OF NITRIC-OXIDE ON RAT CARDIAC FIBROBLAST PROLIFERATION INDUCED BY ANGIOTENSIN-II
    Hypertension
    
    T. Takizawa et al., "THE EFFECT OF NITRIC-OXIDE ON RAT CARDIAC FIBROBLAST PROLIFERATION INDUCED BY ANGIOTENSIN-II", Hypertension, 28(3), 1996, pp. 40-40
12. KATO H; HOU J; CHOBANIAN AV; BRECHER P
    EFFECTS OF ANGIOTENSIN-II INFUSION AND INHIBITION OF NITRIC-OXIDE SYNTHASE ON THE RAT AORTA
    Hypertension
    
    H. Kato et al., "EFFECTS OF ANGIOTENSIN-II INFUSION AND INHIBITION OF NITRIC-OXIDE SYNTHASE ON THE RAT AORTA", Hypertension, 28(2), 1996, pp. 153-158
13. LUEPKER RV; JOHNSON SB; BRESLOW L; CHOBANIAN AV; DAVIS CE; DULING BR; KUMANYIKA S; LAUER RM; LAWSON P; MCBRIDE PE; OPARIL S; PRINEAS RJ; WASHINGTON RL
    PHYSICAL-ACTIVITY AND CARDIOVASCULAR HEALTH
    JAMA, the journal of the American Medical Association
    
    R.V. Luepker et al., "PHYSICAL-ACTIVITY AND CARDIOVASCULAR HEALTH", JAMA, the journal of the American Medical Association, 276(3), 1996, pp. 241-246
14. CHOBANIAN AV
    CALCIUM-CHANNEL BLOCKERS - LESSONS LEARNED FROM MIDAS AND OTHER CLINICAL-TRIALS
    JAMA, the journal of the American Medical Association
    
    A.V. Chobanian, "CALCIUM-CHANNEL BLOCKERS - LESSONS LEARNED FROM MIDAS AND OTHER CLINICAL-TRIALS", JAMA, the journal of the American Medical Association, 276(10), 1996, pp. 829-830
15. MORELAND RS; LICHTENSTEIN AH; CHOBANIAN AV
    EFFECTS OF HYPERTENSION ON HYPERCHOLESTEROLEMIA-INDUCED CHANGES IN CONTRACTION OF RABBIT AORTA AND CAROTID-ARTERY
    European journal of pharmacology
    
    R.S. Moreland et al., "EFFECTS OF HYPERTENSION ON HYPERCHOLESTEROLEMIA-INDUCED CHANGES IN CONTRACTION OF RABBIT AORTA AND CAROTID-ARTERY", European journal of pharmacology, 307(1), 1996, pp. 55-64
16. FARIVAR RS; CHOBANIAN AV; BRECHER P
    SALICYLATE OR ASPIRIN INHIBITS THE INDUCTION OF THE INDUCIBLE NITRIC-OXIDE SYNTHASE IN RAT CARDIAC FIBROBLASTS
    Circulation research
    
    R.S. Farivar et al., "SALICYLATE OR ASPIRIN INHIBITS THE INDUCTION OF THE INDUCIBLE NITRIC-OXIDE SYNTHASE IN RAT CARDIAC FIBROBLASTS", Circulation research, 78(5), 1996, pp. 759-768
17. CHOBANIAN AV
    HAVE LONG-TERM BENEFITS OF ANTIHYPERTENSIVE THERAPY BEEN UNDERESTIMATED - PROVOCATIVE FINDINGS FROM THE FRAMINGHAM HEART-STUDY
    Circulation
    
    A.V. Chobanian, "HAVE LONG-TERM BENEFITS OF ANTIHYPERTENSIVE THERAPY BEEN UNDERESTIMATED - PROVOCATIVE FINDINGS FROM THE FRAMINGHAM HEART-STUDY", Circulation, 93(4), 1996, pp. 638-640
18. CHOBANIAN AV; ALEXANDER RW
    EXACERBATION OF ATHEROSCLEROSIS BY HYPERTENSION - POTENTIAL MECHANISMS AND CLINICAL IMPLICATIONS
    Archives of internal medicine
    
    A.V. Chobanian e R.W. Alexander, "EXACERBATION OF ATHEROSCLEROSIS BY HYPERTENSION - POTENTIAL MECHANISMS AND CLINICAL IMPLICATIONS", Archives of internal medicine, 156(17), 1996, pp. 1952-1956
19. KATO H; HOU J; CHOBANIAN AV; BRECHER P
    EFFECTS OF ANGIOTENSIN-II INFUSION AND INHIBITION OF NITRIC-OXIDE SYNTHASE ON THE RAT AORTA
    The FASEB journal
    
    H. Kato et al., "EFFECTS OF ANGIOTENSIN-II INFUSION AND INHIBITION OF NITRIC-OXIDE SYNTHASE ON THE RAT AORTA", The FASEB journal, 9(3), 1995, pp. 609-609
20. ZHANG H; CHOBANIAN AV; BRECHER P
    AORTIC ADVENTITIA IS A SOURCE OF NITRIC-OXIDE - A POSSIBLE PARACRINE ROLE
    Hypertension
    
    H. Zhang et al., "AORTIC ADVENTITIA IS A SOURCE OF NITRIC-OXIDE - A POSSIBLE PARACRINE ROLE", Hypertension, 26(3), 1995, pp. 569-569
21. CHOBANIAN AV; HOPE S; BRECHER P
    DISSOCIATION BETWEEN THE ANTIATHEROSCLEROTIC EFFECT OF TRANDOLAPRIL AND SUPPRESSION OF SERUM AND AORTIC ANGIOTENSIN-CONVERTING ENZYME-ACTIVITY IN THE WATANABE HERITABLE HYPERLIPIDEMIC RABBIT
    Hypertension
    
    A.V. Chobanian et al., "DISSOCIATION BETWEEN THE ANTIATHEROSCLEROTIC EFFECT OF TRANDOLAPRIL AND SUPPRESSION OF SERUM AND AORTIC ANGIOTENSIN-CONVERTING ENZYME-ACTIVITY IN THE WATANABE HERITABLE HYPERLIPIDEMIC RABBIT", Hypertension, 25(6), 1995, pp. 1306-1310
22. FARIVAR RS; CRAWFORD DC; CHOBANIAN AV; BRECHER P
    EFFECT OF ANGIOTENSIN-II BLOCKADE ON THE FIBROPROLIFERATIVE RESPONSE TO PHENYLEPHRINE IN THE RAT-HEART
    Hypertension
    
    R.S. Farivar et al., "EFFECT OF ANGIOTENSIN-II BLOCKADE ON THE FIBROPROLIFERATIVE RESPONSE TO PHENYLEPHRINE IN THE RAT-HEART", Hypertension, 25(4), 1995, pp. 809-813
23. HOU J; KATO H; COHEN RA; CHOBANIAN AV; BRECHER P
    ANGIOTENSIN-II-INDUCED CARDIAC FIBROSIS IN THE RAT IS INCREASED BY CHRONIC INHIBITION OF NITRIC-OXIDE SYNTHASE
    The Journal of clinical investigation
    
    J. Hou et al., "ANGIOTENSIN-II-INDUCED CARDIAC FIBROSIS IN THE RAT IS INCREASED BY CHRONIC INHIBITION OF NITRIC-OXIDE SYNTHASE", The Journal of clinical investigation, 96(5), 1995, pp. 2469-2477
24. CHOBANIAN AV; WEBER MA
    CARDIOVASCULAR AND METABOLIC ACTIONS OF A NEW CLASS OF CALCIUM-CHANNEL BLOCKERS - INTRODUCTION - PROCEEDINGS FROM AN OFFICIAL SATELLITE SYMPOSIUM TO THE 15TH SCIENTIFIC MEETING OF THE INTERNATIONAL-SOCIETY-OF-HYPERTENSION
    American journal of hypertension
    
    A.V. Chobanian e M.A. Weber, "CARDIOVASCULAR AND METABOLIC ACTIONS OF A NEW CLASS OF CALCIUM-CHANNEL BLOCKERS - INTRODUCTION - PROCEEDINGS FROM AN OFFICIAL SATELLITE SYMPOSIUM TO THE 15TH SCIENTIFIC MEETING OF THE INTERNATIONAL-SOCIETY-OF-HYPERTENSION", American journal of hypertension, 7(10), 1994, pp. 190000117-190000118
25. CHOBANIAN AV
    CAN ANTIHYPERTENSIVE DRUGS REDUCE ATHEROSCLEROSIS AND ITS CLINICAL COMPLICATIONS
    American journal of hypertension
    
    A.V. Chobanian, "CAN ANTIHYPERTENSIVE DRUGS REDUCE ATHEROSCLEROSIS AND ITS CLINICAL COMPLICATIONS", American journal of hypertension, 7(10), 1994, pp. 190000119-190000125
26. NICKERSON CJ; PAVLOVARESOKOVA A; CHOBANIAN AV; BRECHER P
    TRANSFORMING GROWTH-FACTOR-BETA EXPRESSION IN THE HEART AND AORTA OF THE HYPERTENSIVE RAT
    The FASEB journal
    
    C.J. Nickerson et al., "TRANSFORMING GROWTH-FACTOR-BETA EXPRESSION IN THE HEART AND AORTA OF THE HYPERTENSIVE RAT", The FASEB journal, 8(7), 1994, pp. 10001460-10001460
27. FARIVAR S; CRAWFORD DC; HIMENO H; CHOBANIAN AV; BRECHER P
    ROLE OF ANGIOTENSIN-II BLOCKADE BY LOSARTAN IN PHENYLEPHRINE-INDUCED CARDIAC INJURY
    Hypertension
    
    S. Farivar et al., "ROLE OF ANGIOTENSIN-II BLOCKADE BY LOSARTAN IN PHENYLEPHRINE-INDUCED CARDIAC INJURY", Hypertension, 24(3), 1994, pp. 406-406
28. HIMENO H; CRAWFORD DC; HOSOI M; CHOBANIAN AV; BRECHER P
    ANGIOTENSIN-II ALTERS AORTIC FIBRONECTIN INDEPENDENTLY OF HYPERTENSION
    Hypertension
    
    H. Himeno et al., "ANGIOTENSIN-II ALTERS AORTIC FIBRONECTIN INDEPENDENTLY OF HYPERTENSION", Hypertension, 23(6), 1994, pp. 823-826
29. FARMER RG; CHOBANIAN AV
    HEALTH-CARE IN ARMENIA TODAY
    Western journal of medicine
    
    R.G. Farmer e A.V. Chobanian, "HEALTH-CARE IN ARMENIA TODAY", Western journal of medicine, 160(4), 1994, pp. 331-334
30. CRAWFORD DC; CHOBANIAN AV; BRECHER P
    ANGIOTENSIN-II INDUCES FIBRONECTIN EXPRESSION ASSOCIATED WITH CARDIACFIBROSIS IN THE RAT
    Circulation research
    
    D.C. Crawford et al., "ANGIOTENSIN-II INDUCES FIBRONECTIN EXPRESSION ASSOCIATED WITH CARDIACFIBROSIS IN THE RAT", Circulation research, 74(4), 1994, pp. 727-739
31. HOU J; KATO H; CHOBANIAN AV; BRECHER P
    INFLUENCE OF NITRIC-OXIDE SYNTHASE INHIBITION ON CARDIAC FIBROSIS INDUCED BY ANGIOTENSIN-II INFUSION
    Circulation
    
    J. Hou et al., "INFLUENCE OF NITRIC-OXIDE SYNTHASE INHIBITION ON CARDIAC FIBROSIS INDUCED BY ANGIOTENSIN-II INFUSION", Circulation, 90(4), 1994, pp. 627-627
32. HOU J; KATO H; CHOBANIAN AV; BRECHER P
    INFLUENCE OF NITRIC-OXIDE SYNTHASE INHIBITION ON CARDIAC FIBROSIS INDUCED BY ANGIOTENSIN-II INFUSION
    Circulation
    
    J. Hou et al., "INFLUENCE OF NITRIC-OXIDE SYNTHASE INHIBITION ON CARDIAC FIBROSIS INDUCED BY ANGIOTENSIN-II INFUSION", Circulation, 90(4), 1994, pp. 627-627
33. HIMENO H; HOSOI M; BRECHER P; CHOBANIAN AV
    ANGIOTENSIN-II ALTERS FIBRONECTIN GENE-EXPRESSION IN RAT AORTIC TISSUE BY A MECHANISM INDEPENDENT OF BLOOD-PRESSURE ELEVATION
    Hypertension
    
    H. Himeno et al., "ANGIOTENSIN-II ALTERS FIBRONECTIN GENE-EXPRESSION IN RAT AORTIC TISSUE BY A MECHANISM INDEPENDENT OF BLOOD-PRESSURE ELEVATION", Hypertension, 22(3), 1993, pp. 414-414
34. HOSOI M; TAKASAKI I; PAVLOVAREZAKOVA A; HIMENO H; CHOBANIAN AV; BRECHER P
    SELECTIVE INDUCTION OF AN EMBRYONIC FIBRONECTIN ISOFORM IN THE RAT AORTA IN-VITRO
    Circulation research
    
    M. Hosoi et al., "SELECTIVE INDUCTION OF AN EMBRYONIC FIBRONECTIN ISOFORM IN THE RAT AORTA IN-VITRO", Circulation research, 73(4), 1993, pp. 689-695